Pharming Group (Netherlands) Top Management

Pharming Group Management Team Effectiveness

The company has return on total asset (ROA) of 0.0576 % which means that it generated a profit of $0.0576 on every $100 spent on assets. This is way below average. Pharming Group's management efficiency ratios could be used to measure how well Pharming Group manages its routine affairs as well as how well it operates its assets and liabilities. As of February 24, 2026, Return On Tangible Assets is expected to decline to -0.03. In addition to that, Return On Capital Employed is expected to decline to -0.01. At present, Pharming Group's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 324.8 M, whereas Non Current Assets Total are forecasted to decline to about 75.6 M. The current year's Common Stock Shares Outstanding is expected to grow to about 832.2 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 16.5 MPharming Group owns a total of 696.69 Million outstanding shares. Roughly 75.99 pct. of Pharming Group outstanding shares are held by general public with 2.22 % owned by insiders and only 21.79 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Pharming Group in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pharming Group, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Pharming Group Workforce Comparison

Pharming Group NV Benchmark Summation

Pharming Group Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Pharming Group NV often depends on how effective the management is. Pharming Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharming management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharming management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Pharming Group's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pharming Group's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pharming Group's management manipulating its earnings.

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.